Edition:
United States

Core Laboratories NV (CLB.N)

CLB.N on New York Stock Exchange

112.54USD
4:02pm EDT
Change (% chg)

$2.96 (+2.70%)
Prev Close
$109.58
Open
$110.00
Day's High
$112.82
Day's Low
$109.77
Volume
55,759
Avg. Vol
80,583
52-wk High
$135.30
52-wk Low
$96.30

Latest Key Developments (Source: Significant Developments)

Core Laboratories CEO David Demshur's 2016 total compensation was $6.2 mln
Friday, 24 Mar 2017 04:09pm EDT 

Core Laboratories Nv - :CEO David Demshur's fy 2016 total compensation was $6.2 million versus $6.6 million in fy 2015 - sec filing.  Full Article

Core Lab reports Q4 earnings per share $0.35
Wednesday, 25 Jan 2017 04:15pm EST 

Core Laboratories Nv - : Core Lab reports fourth quarter 2016 results: . Q4 gaap earnings per share $0.35 . Q4 revenue $150 million . Sees Q1 2017 gaap earnings per share $0.38 . Q4 earnings per share view $0.40, revenue view $145.5 million -- Thomson Reuters I/B/E/S . Q1 earnings per share view $0.42 -- Thomson Reuters I/B/E/S .Quarterly ex-items eps of $0.41.  Full Article

Core Laboratories reports Q4 earnings per share $0.35
Wednesday, 25 Jan 2017 04:06pm EST 

Core Laboratories Nv : Qtrly earnings per share $0.35 . Qtrly adjusted earnings per share $0.41 . Q4 2016 revenue of $149.5 million up over 4% sequentially from Q3 2016 . Q4 earnings per share view $0.40, revenue view $145.5 million -- Thomson Reuters I/B/E/S . On a GAAP basis, core has projected eps for q1 of 2017 to be $0.38 .Q1 earnings per share view $0.42 -- Thomson Reuters I/B/E/S.  Full Article

Core Laboratories N.V. Q2 revenue of $148.1 mln decreased 3.6 pct sequentially
Wednesday, 20 Jul 2016 04:08pm EDT 

Core Laboratories N.V. : Second quarter EPS of $0.38 GAAP; EPS of $0.35, excluding items . At current activity levels, core predicts 2016 U.S. onshore oil production will fall approximately 1,100,000 bopd . Second quarter revenue of $148.1 million decreased 3.6 pct sequentially .Q2 earnings per share view $0.35, revenue view $146.4 million -- Thomson Reuters I/B/E/S.  Full Article

Core Lab prices upsized public offering of 1.5 mln share
Wednesday, 11 May 2016 08:48pm EDT 

Core Laboratories Nv : Says upsized pricing of an underwritten public offering of 1,475,000 shares of its common stock . Gross proceeds of offering (before underwriter's discounts and commissions and estimated offering expenses) will be about $175 million .Core Lab announces upsizing and pricing of public offering of common stock.  Full Article

Core Lab prices upsized public offering of 1.5 mln share
Wednesday, 11 May 2016 07:59pm EDT 

Core Laboratories Nv : Says upsized pricing of an underwritten public offering of 1,475,000 shares of its common stock . Gross proceeds of offering (before underwriter's discounts and commissions and estimated offering expenses) will be about $175 million .Core Lab announces upsizing and pricing of public offering of common stock.  Full Article

Core laboratories NV files for stock shelf of up to 1.3 mln shares
Wednesday, 11 May 2016 06:14pm EDT 

Core Laboratories NV :Core Laboratories NV files for stock shelf of up to 1.3 million shares of common stock - SEC Filing.  Full Article

Core Laboratories commences underwritten public offering of 1.3 mln shares
Wednesday, 11 May 2016 04:50pm EDT 

Core Laboratories NV : Commenced a registered underwritten public offering of 1,300,000 shares of its common stock .Proceeds from offering will be used to repay a portion of outstanding borrowings under our revolving credit facility.  Full Article

Core Laboratories NV announces Q2 quarterly dividend
Thursday, 14 Apr 2016 04:15pm EDT 

Core Laboratories NV:Cash dividend of $0.55 per share of common stock payable in the second quarter of 2016.Says dividend will be payable on May 24 to shareholders of record date as on May 4.  Full Article

Core Laboratories NV gives Q1 2016 guidance
Wednesday, 27 Jan 2016 05:16pm EST 

Core Laboratories NV:Says on a consolidated basis, Core projects Q1 2016 revenue to fall sequentially approximately 10% to $164,000,000, with operating income falling to approximately $26,000,000 to $28,000,000.Says Q1 2016 EPS is projected to be approximately $0.41 to $0.43.  Full Article

More From Around the Web

BRIEF-Core Laboratories CEO David Demshur's 2016 total compensation was $6.2 mln

* CEO David Demshur's fy 2016 total compensation was $6.2 million versus $6.6 million in fy 2015 - sec filing Source text: [http://bit.ly/2oer7bh] Further company coverage: